Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nagarajah

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nuklearmedizin. Nuclear Medicine|April 26, 2012
Pioglitazone therapy in progressive differentiated thyroid carcinomaS J Rosenbaum-Krumme, A Bockisch, J Nagarajah
Nuklearmedizin. Nuclear Medicine|February 28, 2012
18F-fluoride PET/CT for bone scanning. Role of attenuation correctionJ Nagarajah, T Dannat, V Hartung, et al.
Nuklearmedizin. Nuclear Medicine|July 10, 2012
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinS J Rosenbaum-Krumme, M Wieduwilt, J Nagarajah, et al.
Nuklearmedizin. Nuclear Medicine|August 16, 2012
124I-PET/CT images of differentiated thyroid cancer patients. Distinguishing lymph node metastases from thyroid remnants using kinetic quantitiesS Rosenbaum-Krumme, J Nagarajah, M Ruhlmann, et al.
Nuklearmedizin. Nuclear Medicine|May 4, 2012
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodulesJ Nagarajah, J Farahati, R Görges, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2013
18FDG-PET to assess recurrence and long term survival in patients with malignant melanomaH A Wieder, G Tekin, S Rosenbaum-Krumme, et al.
Nuklearmedizin. Nuclear Medicine|April 25, 2012
[Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma]V Hartung-Knemeyer, S Müller, J Nagarajah, et al.
Journal of Medical Economics|March 11, 2023
Costs of radium-223 and the pharmacy preparation <sup>177</sup>Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitalsS W Quist, J H J Paulissen, D N J Wyndaele, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2014
Diagnosis of hyperfunctional thyroid nodules: impact of US-elastographyM Ruhlmann, V Stebner, R Görges, et al.
Archives of Gynecology and Obstetrics|June 26, 2014
Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndromeAngela Köninger, L Koch, P Edimiris, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nuklearmedizin. Nuclear Medicine|April 26, 2012
Pioglitazone therapy in progressive differentiated thyroid carcinomaS J Rosenbaum-Krumme, A Bockisch, J Nagarajah
Nuklearmedizin. Nuclear Medicine|February 28, 2012
18F-fluoride PET/CT for bone scanning. Role of attenuation correctionJ Nagarajah, T Dannat, V Hartung, et al.
Nuklearmedizin. Nuclear Medicine|July 10, 2012
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinS J Rosenbaum-Krumme, M Wieduwilt, J Nagarajah, et al.
Nuklearmedizin. Nuclear Medicine|August 16, 2012
124I-PET/CT images of differentiated thyroid cancer patients. Distinguishing lymph node metastases from thyroid remnants using kinetic quantitiesS Rosenbaum-Krumme, J Nagarajah, M Ruhlmann, et al.
Nuklearmedizin. Nuclear Medicine|May 4, 2012
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodulesJ Nagarajah, J Farahati, R Görges, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2013
18FDG-PET to assess recurrence and long term survival in patients with malignant melanomaH A Wieder, G Tekin, S Rosenbaum-Krumme, et al.
Nuklearmedizin. Nuclear Medicine|April 25, 2012
[Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma]V Hartung-Knemeyer, S Müller, J Nagarajah, et al.
Journal of Medical Economics|March 11, 2023
Costs of radium-223 and the pharmacy preparation <sup>177</sup>Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitalsS W Quist, J H J Paulissen, D N J Wyndaele, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2014
Diagnosis of hyperfunctional thyroid nodules: impact of US-elastographyM Ruhlmann, V Stebner, R Görges, et al.
Archives of Gynecology and Obstetrics|June 26, 2014
Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndromeAngela Köninger, L Koch, P Edimiris, et al.
Pageof 2